Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 2,976–3,000 of 27,380 studies, newest first · page 120 of 1096.

October 2025 25

  1. 2025-10-07

    Early detection of Alzheimer's disease: From multiplex assays and imaging to point of care devices and AI-based functional monitoring

    ✓ Peer-reviewed Cognitive tests and assessment Journal of Alzheimer's disease : JAD

    Key finding: The advent of disease-modifying treatments and risk-reduction strategies in the clinic have increased the demand for biomarkers for early disease detection, prediction of clinical course of disease, individual risk prediction and monitoring of treatment effects. +1 more finding

  2. 2025-10-07

    Mitochondrial blood-based biomarker is related to cardiorespiratory fitness and aging in a sex-dependent manner

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (New York, N. Y.)

    Key finding: As expected, males had higher lean mass and VO2peak than females (p = 0.01), but groups did not differ in body mass index (p = 0.51). +4 more findings

  3. 2025-10-07

    Simulation of Alzheimer's diagnostic flows with blood biomarker test options in Japan

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (New York, N. Y.)

    Key finding: The maximum mean wait time under the current workflow was projected at 6.4 months, decreasing with BBM integration. +4 more findings

  4. 2025-10-07

    Neurofilament Biomarkers in Neurology: From Neuroinflammation to Neurodegeneration, Bridging Established and Novel Analytical Advances with Clinical Practice

    ✓ Peer-reviewed Inflammation and the immune system International Journal of Molecular Sciences

    Key finding: In multiple sclerosis (MS), serum NfL correlates with disease activity, treatment response, and long-term disability, and may complement MRI in monitoring subclinical progression. +4 more findings

  5. 2025-10-07

    Compositional Control of Aging Kinetics in TDP-43 Condensates

    ✓ Peer-reviewed Brain tissue and pathology PRX Life

    Key finding: Together, our findings underscore the major role of client biomolecules in controlling the propensity of multicomponent condensates to form harmful solidlike states.

  6. 2025-10-07

    Glymphatic activity is linked to the synaptic vesicle cycle pathway in frontotemporal dementia: A metabolomics study

    ✓ Peer-reviewed Lewy body dementia Neurobiology of Disease

    Key finding: We aimed to explore potential underlying metabolic pathways associated with glymphatic dysfunction in FTD. +2 more findings

  7. 2025-10-07

    A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia

    ✓ Peer-reviewed Lewy body dementia Brain

    Key finding: We present the pharmacological properties of EKZ-438, which demonstrate high selectivity for HDAC6 (>8500-fold selectivity for HDAC6 versus all other HDAC6 paralogues), low nanomolar potency (12 nM) for HDAC6, and importantly, CNS-penetrance (unbound brain-to-plasma partition coefficient [Kp,uu,brain] ≥ 0.55) and high oral bioavailability (fraction of dose absorbed [F%] = 70). +2 more findings

  8. 2025-10-07
  9. 2025-10-06

    Regional tau PET patterns predict prospective domain-specific cognitive decline in early symptomatic Alzheimer's disease

    ✓ Peer-reviewed Brain scans and imaging Alzheimer's research & therapy

    Key finding: Differential FTP-PET signal patterns showed significant negative associations with domain-specific annual rates of decline. +4 more findings

  10. 2025-10-06

    A Biomarker-Based Classification of Corticobasal Syndrome

    ✓ Peer-reviewed Brain scans and imaging Movement disorders : official journal of the Movement Disorder Society

    Key finding: Tau positivity was found in 90% of CBS cases, Aβ in 28%, and αSyn in 24%. +4 more findings

  11. 2025-10-06

    Living well with dementia: a qualitative interview study on family caregivers’ call for more person- and family-centered dementia support

    ✓ Peer-reviewed Caregiving BMC Geriatrics

    Key finding: Three themes were identified: (1) Struggling with conflicting emotions and social challenges - caregivers reported experiencing stress, physical exhaustion, and emotional strain due to constant availability and the challenges of managing behavioral changes, further intensified by isolation and shrinking social networks. +4 more findings

  12. 2025-10-06

    Latino Caregiver Experiences With Dementia Care and Healthcare Navigation

    ✓ Peer-reviewed Caregiving Journal of the American Geriatrics Society

    Key finding: We identified two main themes (each with subthemes) that influence Latino dementia caregiver experiences with healthcare: (1) caregiving and understanding of dementia shaped by individual, family, and social factors (subthemes: Caregiver's own understanding of dementia; Lack of support and understanding from family; Latino cultural perspectives on dementia); and (2) navigating formal services amid gaps in cultural alignment and support (subthemes: Trial and error: education and resource gaps; Cultural tension with healthcare). +3 more findings

  13. 2025-10-06

    Varicella-zoster virus reactivation and the risk of dementia

    ✓ Peer-reviewed Prevention and risk Nature Medicine

    Key finding: VZV reactivation is associated with a wide range of symptoms, including herpes zoster (HZ; also known as shingles), and has been implicated in the development of dementia, although to an unknown extent. +3 more findings

  14. 2025-10-06

    Krankheitsmodifizierende Therapie mit Lecanemab bei früher Alzheimer-Demenz

    ✓ Peer-reviewed Treatments Fortschritte der Neurologie · Psychiatrie

    Key finding: Erstens sollen homozygote ApoE4 Träger und zweitens Patienten, die eine orale Antikoagulantien erhalten, Lecanemab nicht erhalten. +4 more findings

  15. 2025-10-06

    Alzheimer Disease, Vascular Disease, and Blood-Brain Barrier Permeability Biomarkers in Middle-Aged Adults

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: The findings suggest that permeability of the blood-brain barrier is linked to AD pathophysiology, contributes to cerebrovascular lesions observed on MRI, and is associated with neuroinflammation in middle age. +4 more findings

  16. 2025-10-05

    Benzoxazole Derivatives as Dual p38α Mitogen‐Activated Protein Kinase and Acetylcholinesterase Inhibitors: Design, Synthesis, and Evaluation for Alzheimer's Disease and Cancer Therapy

    ✓ Peer-reviewed Disease mechanisms ChemMedChem

    Key finding: Additionally, dysregulation of p38α MAPK is associated with tumorigenesis, making it a promising target for both neurodegenerative and proliferative diseases. +1 more finding

  17. 2025-10-04

    Meta meta-analysis of cardiovascular risk factors in Alzheimer's disease

    ✓ Peer-reviewed Risk factors eNeurologicalSci

    Key finding: The total effect of cholesterol on risk of AD was significant and heterogeneous. +4 more findings

  18. 2025-10-04

    Urban–rural disparities in dementia-related mortality among older adults in the U.S. from 1999 to 2020

    ✓ Peer-reviewed Disparities Archives of Gerontology and Geriatrics Plus

    Key finding: In rural areas, 61.8 % of dementia deaths occurred in nursing homes compared to 53.9 % in urban areas. +2 more findings

  19. 2025-10-04

    Precision prevention in exercise: Integrating OMICS biomarkers and artificial intelligence for injury risk assessment

    ✓ Peer-reviewed Prevention and risk Advanced Exercise and Health Science

    Key finding: Exercise injuries present a significant challenge in medicine and public health, impacting exercise performance, career longevity, and overall quality of life. +2 more findings

  20. 2025-10-03

    Semaglutide and the pathogenesis of progressive neurodegenerative disease: the central role of mitochondria

    ✓ Peer-reviewed Drug development Frontiers in neuroendocrinology

    Key finding: Primary mitochondrial disorders (e.g., Leigh syndrome) are uniformly associated with profound neurodegeneration. +1 more finding

  21. 2025-10-03
  22. 2025-10-03

    Global burden, quality of care, and cross-country inequalities in Alzheimer’s disease and other dementias from 1990 to 2021

    ✓ Peer-reviewed Disparities Journal of Global Health

    Key finding: The global age-standardised DALY rates of ADRDs per 100 000 population slightly increased from 1331.59 (95% confidence interval (CI) = 881.57, 1781.61) in 1990 to 1347.24 (95% CI = 906.36, 1788.12) in 2021, with an AAPC of 0.04% (95% CI = 0.02, 0.05). +4 more findings

  23. 2025-10-03

    Association between different types of lung cancer and neurodegenerative diseases: A two-sample Mendelian randomization study

    ✓ Peer-reviewed Genetics Medicine

    Key finding: Previous observational studies demonstrated that lung cancer and both Alzheimer disease (AD) and Parkinson disease (PD) may be related. +4 more findings

  24. 2025-10-03

    Exploring causal relationships between epigenetic age acceleration and Alzheimer’s disease: a bidirectional Mendelian randomization study

    ✓ Peer-reviewed Genetics Clinical Epigenetics

    Key finding: Employing the random-effects IVW approach, we found that, as indicated by GrimAge, EAA was associated with an increased risk of AD (Odds Ratio [OR] = 1.025, 95% Confidence Interval [CI]: 1.006-1.044, p = 0.009). +4 more findings

  25. 2025-10-03

    Longitudinal Association of a Polygenic Risk Score for Plasma T-Tau With Incident Alzheimer Dementia and Mild Cognitive Impairment

    ✓ Peer-reviewed Genetics Neurology

    Key finding: In the HELIAD sample, among 618 cognitively healthy participants (mean age 73.37 years, 58.4% female), followed for 2.92 ± 0.80 years, 73 developed AD/aMCI. +4 more findings

Browse the library by subject, with the full score breakdown →